Beilstein J Org Chem. 2014 Mar 04;10:544-98. doi: 10.3762/bjoc.10.50. eCollection 2014.
Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.
Beilstein journal of organic chemistry
Gijs Koopmanschap, Eelco Ruijter, Romano Va Orru
Affiliations
Affiliations
- Department of Chemistry & Pharmaceutical Sciences, Amsterdam Institute of Molecules, Medicines and Systems, VU University Amsterdam, de Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands.
PMID: 24605172
PMCID: PMC3943360 DOI: 10.3762/bjoc.10.50
Abstract
In the recent past, the design and synthesis of peptide mimics (peptidomimetics) has received much attention. This because they have shown in many cases enhanced pharmacological properties over their natural peptide analogues. In particular, the incorporation of cyclic constructs into peptides is of high interest as they reduce the flexibility of the peptide enhancing often affinity for a certain receptor. Moreover, these cyclic mimics force the molecule into a well-defined secondary structure. Constraint structural and conformational features are often found in biological active peptides. For the synthesis of cyclic constrained peptidomimetics usually a sequence of multiple reactions has been applied, which makes it difficult to easily introduce structural diversity necessary for fine tuning the biological activity. A promising approach to tackle this problem is the use of multicomponent reactions (MCRs), because they can introduce both structural diversity and molecular complexity in only one step. Among the MCRs, the isocyanide-based multicomponent reactions (IMCRs) are most relevant for the synthesis of peptidomimetics because they provide peptide-like products. However, these IMCRs usually give linear products and in order to obtain cyclic constrained peptidomimetics, the acyclic products have to be cyclized via additional cyclization strategies. This is possible via incorporation of bifunctional substrates into the initial IMCR. Examples of such bifunctional groups are N-protected amino acids, convertible isocyanides or MCR-components that bear an additional alkene, alkyne or azide moiety and can be cyclized via either a deprotection-cyclization strategy, a ring-closing metathesis, a 1,3-dipolar cycloaddition or even via a sequence of multiple multicomponent reactions. The sequential IMCR-cyclization reactions can afford small cyclic peptide mimics (ranging from four- to seven-membered rings), medium-sized cyclic constructs or peptidic macrocycles (>12 membered rings). This review describes the developments since 2002 of IMCRs-cyclization strategies towards a wide variety of small cyclic mimics, medium sized cyclic constructs and macrocyclic peptidomimetics.
Keywords: heterocycles; isocyanides; macrocycles; medicinal chemistry; multicomponent reaction; organic synthesis; peptidomimetics
References
- Amino Acids. 2008 Jan;34(1):1-24 - PubMed
- J Org Chem. 2002 May 3;67(9):3057-64 - PubMed
- J Pept Sci. 2003 Aug;9(8):471-501 - PubMed
- Chem Rev. 2012 Jun 13;112(6):3083-135 - PubMed
- Org Lett. 2002 Apr 4;4(7):1167-70 - PubMed
- J Am Chem Soc. 2010 Mar 10;132(9):2889-91 - PubMed
- Annu Rev Cell Dev Biol. 1996;12:697-715 - PubMed
- Bioorg Med Chem Lett. 2004 Nov 15;14(22):5689-92 - PubMed
- Bioorg Med Chem Lett. 2006 Jul 1;16(13):3463-8 - PubMed
- Chemistry. 2011 Oct 24;17(44):12257-61 - PubMed
- Mol Divers. 2003;6(3-4):227-35 - PubMed
- Arch Pharm (Weinheim). 2001 May;334(5):167-72 - PubMed
- Chemistry. 2004 Jul 5;10(13):3286-300 - PubMed
- J Org Chem. 2008 Jan 18;73(2):719-22 - PubMed
- Science. 1980 Nov 7;210(4470):656-8 - PubMed
- J Am Chem Soc. 2002 Mar 20;124(11):2560-7 - PubMed
- J Org Chem. 2006 Oct 13;71(21):8244-9 - PubMed
- J Am Chem Soc. 2002 Nov 6;124(44):13097-105 - PubMed
- J Am Chem Soc. 2005 Jan 19;127(2):506-7 - PubMed
- J Med Chem. 2006 Oct 5;49(20):6133-7 - PubMed
- Mol Divers. 2010 Feb;14(1):59-65 - PubMed
- Org Biomol Chem. 2008 Sep 7;6(17):3158-65 - PubMed
- Bioorg Med Chem Lett. 2012 Apr 1;22(7):2598-603 - PubMed
- Chem Soc Rev. 2011 Aug;40(8):4295-306 - PubMed
- Org Biomol Chem. 2012 Feb 14;10(6):1255-74 - PubMed
- Org Lett. 2006 Aug 31;8(18):4145-8 - PubMed
- Org Lett. 2002 May 30;4(11):1967-9 - PubMed
- Biol Pharm Bull. 2000 May;23(5):654-6 - PubMed
- J Org Chem. 2008 Mar 7;73(5):1762-7 - PubMed
- Anticancer Drugs. 2006 Jan;17(1):25-31 - PubMed
- Org Lett. 2004 Dec 9;6(25):4771-4 - PubMed
- Chemistry. 2013 May 10;19(20):6417-28 - PubMed
- J Med Chem. 2003 Oct 9;46(21):4393-404 - PubMed
- Nat Prod Rep. 1997 Feb;14(1):75-82 - PubMed
- Org Lett. 2002 Feb 21;4(4):639-41 - PubMed
- Mol Pharm. 2012 Nov 5;9(11):2961-73 - PubMed
- J Med Chem. 2007 Nov 29;50(24):5890-3 - PubMed
- Bioorg Med Chem Lett. 2001 Apr 23;11(8):1065-8 - PubMed
- Bioorg Med Chem Lett. 2005 Aug 15;15(16):3732-6 - PubMed
- Curr Opin Chem Biol. 2002 Jun;6(3):306-13 - PubMed
- J Pept Res. 2005 Feb;65(2):229-60 - PubMed
- Org Biomol Chem. 2010 Feb 7;8(3):529-32 - PubMed
- J Am Chem Soc. 2001 Jul 11;123(27):6700-1 - PubMed
- Angew Chem Int Ed Engl. 2008;47(49):9454-7 - PubMed
- Pharmazie. 2001 Jan;56(1):18-22 - PubMed
- Drugs Today (Barc). 2004 Nov;40(11):901-12 - PubMed
- Chem Soc Rev. 2010 Apr;39(4):1325-37 - PubMed
- Peptides. 2008 Aug;29(8):1305-11 - PubMed
- Bioorg Med Chem Lett. 2007 Mar 1;17(5):1341-5 - PubMed
- Bioorg Med Chem Lett. 2005 Mar 1;15(5):1429-33 - PubMed
- Bioorg Med Chem Lett. 2005 Feb 1;15(3):765-70 - PubMed
- Chem Rev. 2009 Feb;109(2):796-814 - PubMed
- Drug Discov Today. 2003 Dec 15;8(24):1128-37 - PubMed
- Bioorg Med Chem Lett. 2000 Feb 7;10(3):257-60 - PubMed
- J Med Chem. 2004 Jul 29;47(16):4054-9 - PubMed
- Bioorg Med Chem Lett. 2007 Jun 15;17(12):3362-6 - PubMed
- Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6793-8 - PubMed
- J Nat Prod. 2003 Oct;66(10):1299-301 - PubMed
- Org Lett. 2009 Mar 5;11(5):1167-70 - PubMed
- Chem Soc Rev. 2007 Oct;36(10):1674-89 - PubMed
- Chem Rev. 2001 Dec;101(12):3893-4012 - PubMed
- Curr Opin Cell Biol. 2008 Oct;20(5):514-9 - PubMed
- Chem Rev. 2012 Jul 11;112(7):3641-716 - PubMed
- Org Lett. 2006 Nov 9;8(23):5369-72 - PubMed
- J Org Chem. 2007 Mar 16;72(6):2151-60 - PubMed
- Chem Soc Rev. 2012 May 21;41(10):3969-4009 - PubMed
- Chemistry. 2006 Sep 18;12(27):7178-89 - PubMed
- Chem Commun (Camb). 2010 Nov 14;46(42):7918-20 - PubMed
- Org Biomol Chem. 2006 Nov 21;4(22):4236-40 - PubMed
- J Am Chem Soc. 2006 Aug 2;128(30):9699-704 - PubMed
- J Org Chem. 2009 Mar 6;74(5):2189-92 - PubMed
- Beilstein J Org Chem. 2011;7:976-9 - PubMed
- J Org Chem. 2009 Sep 18;74(18):7084-93 - PubMed
- Acc Chem Res. 2001 Oct;34(10):826-35 - PubMed
- J Med Chem. 2008 Feb 28;51(4):988-96 - PubMed
- J Med Chem. 2007 Mar 22;50(6):1347-53 - PubMed
- Org Lett. 2004 Jan 8;6(1):39-42 - PubMed
- J Med Chem. 2005 Jun 16;48(12):3991-4008 - PubMed
- Mol Cancer Ther. 2006 Jan;5(1):160-9 - PubMed
- Chemistry. 2006 Jan 23;12(4):1174-84 - PubMed
- Curr Med Chem. 2005;12(5):589-97 - PubMed
- Curr Opin Pharmacol. 2006 Feb;6(1):18-23 - PubMed
- Eur J Med Chem. 2000 Jan;35(1):53-67 - PubMed
- Chemistry. 2013 Dec 23;19(52):17668-72 - PubMed
- J Org Chem. 2007 Dec 21;72(26):10239-42 - PubMed
- J Org Chem. 2010 Mar 5;75(5):1723-32 - PubMed
- Chem Commun (Camb). 2003 Mar 7;(5):596-7 - PubMed
- J Med Chem. 1995 Mar 3;38(5):771-93 - PubMed
- Angew Chem Int Ed Engl. 2010 Mar 15;49(12):2182-4 - PubMed
- J Med Chem. 1996 Apr 26;39(9):1898-906 - PubMed
- J Antibiot (Tokyo). 1986 Dec;39(12):1674-84 - PubMed
- J Org Chem. 2009 Jan 16;74(2):660-8 - PubMed
- J Nat Prod. 2007 Nov;70(11):1793-5 - PubMed
- Chem Commun (Camb). 2004 Sep 21;(18):2011-5 - PubMed
- Org Lett. 2003 Apr 3;5(7):1047-50 - PubMed
- Bioorg Med Chem. 2010 Oct 15;18(20):7193-202 - PubMed
- Mini Rev Med Chem. 2004 Jan;4(1):69-92 - PubMed
- Chem Biol Drug Des. 2010 Aug;76(2):116-29 - PubMed
- Nat Chem. 2011 Jun 23;3(7):509-24 - PubMed
- J Med Chem. 2004 Nov 4;47(23):5713-20 - PubMed
- J Antibiot (Tokyo). 2003 Feb;56(2):102-6 - PubMed
- J Med Chem. 2006 Jun 1;49(11):3064-7 - PubMed
- J Med Chem. 1991 May;34(5):1594-605 - PubMed
- J Agric Food Chem. 2005 Sep 7;53(18):7222-31 - PubMed
- Nature. 2005 Nov 10;438(7065):248-52 - PubMed
- Mol Divers. 2011 Feb;15(1):3-33 - PubMed
- Org Lett. 2008 Jan 17;10(2):205-8 - PubMed
- J Antibiot (Tokyo). 1987 Apr;40(4):455-8 - PubMed
- Curr Opin Chem Biol. 1998 Aug;2(4):441-52 - PubMed
- Bioorg Med Chem Lett. 2008 Apr 1;18(7):2385-9 - PubMed
- Org Lett. 2007 Nov 22;9(24):5035-8 - PubMed
- Angew Chem Int Ed Engl. 2011 Jul 4;50(28):6234-46 - PubMed
- J Mol Recognit. 1990 Apr;3(2):55-64 - PubMed
- Chem Commun (Camb). 2003 Oct 21;(20):2594-5 - PubMed
- J Med Chem. 1997 Aug 1;40(16):2502-24 - PubMed
- Bioorg Med Chem Lett. 2006 May 15;16(10):2748-52 - PubMed
- Bioorg Med Chem. 2002 Jun;10(6):1813-8 - PubMed
- Tetrahedron. 2012 Jul 8;68(27-28):5606-5611 - PubMed
- Angew Chem Int Ed Engl. 2010 Jul 19;49(31):5289-92 - PubMed
- Chem Rev. 2006 Jan;106(1):17-89 - PubMed
- Mol Divers. 2005;9(1-3):159-69 - PubMed
- J Am Chem Soc. 2004 Jan 21;126(2):444-5 - PubMed
- Chem Rev. 2010 Sep 8;110(9):5235-331 - PubMed
- Org Lett. 2000 Aug 24;2(17):2615-7 - PubMed
- Chem Biol Drug Des. 2010 Aug;76(2):130-41 - PubMed
- Mol Divers. 2003;6(3-4):297-313 - PubMed
- ACS Comb Sci. 2012 Mar 12;14(3):160-3 - PubMed
- J Med Chem. 1992 May 15;35(10):1887-97 - PubMed
- Mol Divers. 2005;9(1-3):171-86 - PubMed
- Bioorg Med Chem Lett. 2000 Jun 5;10(11):1159-62 - PubMed
- J Comb Chem. 2009 Nov-Dec;11(6):1078-82 - PubMed
- J Med Chem. 2010 Sep 23;53(18):6525-38 - PubMed
- J Org Chem. 2002 Apr 5;67(7):2093-100 - PubMed
- Bioorg Med Chem Lett. 2004 Oct 18;14(20):5219-22 - PubMed
- Org Lett. 2001 Mar 22;3(6):877-80 - PubMed
- Tetrahedron Lett. 2012 Apr 11;53(15):1998-2000 - PubMed
- Bioorg Med Chem. 2003 Jun 12;11(12):2551-68 - PubMed
- J Org Chem. 2007 Nov 9;72(23):8980-3 - PubMed
- Mol Divers. 2010 Aug;14(3):425-42 - PubMed
- ACS Comb Sci. 2012 May 14;14(5):309-15 - PubMed
- Eur J Pharmacol. 1997 Mar 19;322(2-3):243-7 - PubMed
- J Med Chem. 2006 Dec 28;49(26):7697-710 - PubMed
- Bioconjug Chem. 2012 Jul 18;23(7):1387-95 - PubMed
- J Org Chem. 2005 Jun 10;70(12):4735-40 - PubMed
- Chemistry. 2010 May 17;16(19):5528-37 - PubMed
- J Comb Chem. 2010 Jan-Feb;12(1):206-14 - PubMed
- Angew Chem Int Ed Engl. 1999 Aug;38(15):2096-2152 - PubMed
- Org Biomol Chem. 2008 May 21;6(10):1787-95 - PubMed
- Bioorg Med Chem Lett. 2005 Jun 15;15(12):3086-90 - PubMed
- Angew Chem Int Ed Engl. 2007;46(48):9312-5 - PubMed
- Org Biomol Chem. 2005 Jan 7;3(1):97-106 - PubMed
- Chem Commun (Camb). 2011 Jul 21;47(27):7845-7 - PubMed
- Mol Divers. 2012 Aug;16(3):601-6 - PubMed
- Org Lett. 2001 Dec 13;3(25):4079-82 - PubMed
- Bioorg Med Chem Lett. 2005 May 16;15(10):2579-82 - PubMed
- J Med Chem. 2005 Nov 3;48(22):6956-69 - PubMed
- J Org Chem. 2006 Jun 9;71(12):4578-84 - PubMed
- Org Biomol Chem. 2012 Dec 7;10(45):9004-12 - PubMed
- Bioorg Med Chem Lett. 2011 Mar 15;21(6):1823-6 - PubMed
- Angew Chem Int Ed Engl. 2002 Oct 18;41(20):3767-74 - PubMed
- J Comb Chem. 2002 Nov-Dec;4(6):584-90 - PubMed
- J Org Chem. 2008 Feb 15;73(4):1608-11 - PubMed
- Org Biomol Chem. 2010 Dec 7;8(23):5442-7 - PubMed
- J Org Chem. 2001 Oct 19;66(21):7044-50 - PubMed
- Arch Pharm (Weinheim). 2000 Aug;333(8):243-53 - PubMed
Publication Types